$TXMD Balance Sheet | Understand Stock

$TXMD

$1.78 -$0.02 (1.11%) Close

$TXMD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets:
Current assets:
Restricted cash
Accounts receivable, net of allowance for credit losses of $1,621 and $1,334 as of September 30, 2022 and December 31, 2021, respectively
Inventory
Cash and cash equivalents
Royalty receivable, current portion
Prepaid and other current assets
Current assets of discontinued operations
Total current assets
Fixed assets, net

License rights and other intangible assets, net
Right of use assets, net
Royalty receivable, long term
Other non-current assets
Non-current assets of discontinued operations
Total assets

Liabilities and stockholders’ equity:
Current liabilities:
Current maturities of long-term debt
Lender Warrants derivative liability
Make-whole payment derivative liability
Mandatory Redeemable Preferred Stock
Accounts payable
Accrued expenses and other current liabilities
Current liabilities of discontinued operations
Total current liabilities

Long-term debt, net
Operating lease liabilities
Operating lease liabilities
Other non-current liabilities
Total liabilities

Stockholders’ equity:
Preferred stock, par value $0.001; 10,000 shares authorized, none issued
Common stock, par value $0.001; 640,000 and 32,000 shares authorized, 11,574 and 11,574 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit

Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments